The Stroke Team is the engine of the UCSD Stroke Center and the SPOTRIAS proposal, organized to respond immediately to acute stroke. The UCSD Stroke Team is recognized intemationally: we consistently lead recruitment into acute intervention trials. We propose to expand the Team's availability and to show that patients can be treated within 2 hours of symptoms onset. This Core has 3 specific aims: 1) To respond to code stroke 24 hours per day, 7 days per week. To do this, we will continue our current team management, enhanced with SPOTRIAS sponsored research projects. 2) To treat 12 patients per year within 2 hours of stroke onset. Prior data collected here and elsewhere shows that patient enrollment times tend to cluster near the stated upper limit for time to treatment. By moving the accepted 3-hour time window up to two hours, we should obtain even better response rates than expected from typical t-PA use. Further, the procedures required to treat patients within a 2-hour window will have collateral benefits to other patients and SPOTRIAS research trials. 3) To Collect, Review, and use QA data to improve delivery. Our pilot data shows that we can document several important Stroke Code indicators, including door-to-physician, door-to CT scan, door-to-Neurologist, and door-to-needle times. We will use the QA data collected at UCSD and at other hospitals in our network to identify barriers to 60 minute door-to-needle times. This will be coordinated with othere SPOTRIAS centers nationally to assure coherence.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS044148-04
Application #
7553746
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
4
Fiscal Year
2006
Total Cost
$153,731
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Chen, P M; Nguyen, D T; Ho, J P et al. (2018) Factors Influencing Acute Stroke Thrombolytic Treatments in Hispanics In the San Diego Region. Austin J Cerebrovasc Dis Stroke 5:
Lyden, Patrick; Hemmen, Thomas; Grotta, James et al. (2016) Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke 47:2888-2895
Guluma, Kama Z; Liebeskind, David S; Raman, Rema et al. (2015) Feasibility and Safety of Using External Counterpulsation to Augment Cerebral Blood Flow in Acute Ischemic Stroke-The Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial. J Stroke Cerebrovasc Dis 24:2596-604
Neil, William P; Raman, Rema; Hemmen, Thomas M et al. (2015) Association of Hispanic ethnicity with acute ischemic stroke care processes and outcomes. Ethn Dis 25:19-23
Schlick, Konrad H; Hemmen, Thomas M; Lyden, Patrick D (2015) Seizures and Meperidine: Overstated and Underutilized. Ther Hypothermia Temp Manag 5:223-7
Spokoyny, Ilana; Raman, Rema; Ernstrom, Karin et al. (2015) Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients. J Stroke Cerebrovasc Dis 24:1276-81
Spokoyny, Ilana; Raman, Rema; Ernstrom, Karin et al. (2015) Accuracy of First Recorded ""Last Known Normal"" Times of Stroke Code Patients. J Stroke Cerebrovasc Dis 24:2467-73
Coffman, Clarity R; Raman, Rema; Ernstrom, Karin et al. (2015) The ""DeyeCOM Sign"": Predictive Value in Acute Stroke Code Evaluations. J Stroke Cerebrovasc Dis 24:1299-304
Lyden, Patrick D; Hemmen, Thomas M; Grotta, James et al. (2014) Endovascular therapeutic hypothermia for acute ischemic stroke: ICTuS 2/3 protocol. Int J Stroke 9:117-25
Spokoyny, Ilana; Raman, Rema; Ernstrom, Karin et al. (2014) Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients. J Stroke Cerebrovasc Dis 23:1046-50

Showing the most recent 10 out of 53 publications